Drugs / Fecal Microbiome Transplant
Fecal Microbiome Transplant
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT05834010 | Mar 2023 → Jan 2025 | anorexia nervosa | Hvidovre University Hospital | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT03621657 | Mar 2019 → Feb 2020 | Clostridium infectious disease, diarrheal disease | University of Wisconsin, Madison | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fecal Microbiome Transplant | “daily oral Fecal Microbiome Transplant (FMT) as a treatment option” NCT03621657 ↗ |
| Known as | fecal microbiota transplantation | “fecal microbiota transplantation (FMT)” NCT03621657 ↗ |
| Known as | FMT | “daily oral Fecal Microbiome Transplant (FMT) as a treatment option” NCT03621657 ↗ |
| Action | Restore | “thereby restoring balance in the gut microbiota” NCT03621657 ↗ |
| Route | Oral | “administered daily via oral capsules” NCT03621657 ↗ |